| P50 | author | Robert Chunhua Zhao | Q89349255 |
| | Jing Li | Q90910773 |
| P2093 | author name string | Shihua Wang | |
| | Qin Han | |
| | Rongjia Zhu | |
| | Hongling Li | |
| P2860 | cites work | Clinical applications of mesenchymal stem cells | Q21198864 |
| | The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration | Q26775288 |
| | Mesenchymal stem cell secretome and regenerative therapy after cancer | Q27007499 |
| | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
| | Endogenous IL-6 of mesenchymal stem cell improves behavioral outcome of hypoxic-ischemic brain damage neonatal rats by supressing apoptosis in astrocyte | Q28384962 |
| | Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA | Q28744122 |
| | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 |
| | Mesenchymal stem cells | Q29619804 |
| | Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases | Q30318407 |
| | A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype | Q33570359 |
| | The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus | Q33652093 |
| | Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo | Q33851668 |
| | Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice | Q33897644 |
| | Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study | Q34132522 |
| | Mesenchymal stromal cells: current understanding and clinical status | Q34234464 |
| | Direct reprogramming of fibroblasts into neural stem cells by defined factors | Q34263432 |
| | Direct conversion of fibroblasts into stably expandable neural stem cells | Q34263438 |
| | IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease | Q34491107 |
| | Mesenchymal stem cell as salvage treatment for refractory chronic GVHD | Q34562177 |
| | Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. | Q35082549 |
| | Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells | Q35568777 |
| | Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study | Q82808694 |
| | Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease | Q83272771 |
| | [Activin A and BMP-4 induce cardiomyocyte-like cells differentiation of human amniotic epithelial cells] | Q83377906 |
| | Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study | Q84197372 |
| | Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus | Q84311000 |
| | Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study | Q84586351 |
| | Allogeneic mesenchymal stem cells transplantation in patients with refractory RA | Q84752553 |
| | FOXP3 gene expression in multiple sclerosis patients pre- and post mesenchymal stem cell therapy | Q84888368 |
| | Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients | Q84916591 |
| | Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem Cells | Q85317303 |
| | Morphological characteristics and identification of islet-like cells derived from rat adipose-derived stem cells cocultured with pancreas adult stem cells | Q85644469 |
| | [Concept of mesenchymal stem cells: bring more insights into functional research of MSC] | Q86687480 |
| | Direct Conversion Provides Old Neurons from Aged Donor's Skin | Q86858467 |
| | Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: a pilot study | Q95515976 |
| | Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains | Q35630632 |
| | First-in-Human Case Study: Pregnancy in Women With Crohn's Perianal Fistula Treated With Adipose-Derived Stem Cells: A Safety Study. | Q35665316 |
| | Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts into Neuronal Cells by Small Molecules | Q35740228 |
| | Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia | Q35891521 |
| | Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression | Q36067866 |
| | Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus. | Q36102183 |
| | Differentiation of UC-MSCs into hepatocyte-like cells in partially hepatectomized model rats | Q36124920 |
| | Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue | Q36138509 |
| | Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination | Q36187725 |
| | Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome | Q36318183 |
| | Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial | Q36374656 |
| | Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study | Q36488684 |
| | Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation | Q36728560 |
| | Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study | Q36777652 |
| | Reprogramming of bone marrow-derived mesenchymal stem cells into functional insulin-producing cells by chemical regimen | Q36796419 |
| | Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study | Q37022116 |
| | Promotion of hepatic differentiation of bone marrow mesenchymal stem cells on decellularized cell-deposited extracellular matrix | Q37111100 |
| | Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans | Q37246560 |
| | Mesenchymal stem cell homing: the devil is in the details | Q37407769 |
| | Generation of highly purified neural stem cells from human adipose-derived mesenchymal stem cells by Sox1 activation | Q37593537 |
| | The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group | Q37677911 |
| | Stem cell transplantation in multiple sclerosis: current status and future prospects | Q37734210 |
| | Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. | Q37865363 |
| | Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. | Q38032823 |
| | Biologic treatment in Sjögren's syndrome. | Q38262453 |
| | Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia | Q38399591 |
| | Liver from bone marrow in humans. | Q38464633 |
| | Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation | Q38466401 |
| | Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis | Q38696262 |
| | Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury. | Q38988284 |
| | Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation | Q39370071 |
| | Spheroid formation and neural induction in human adipose-derived stem cells on a chitosan-coated surface. | Q39653405 |
| | Clinical Observation of Employment of Umbilical Cord Derived Mesenchymal Stem Cell for Juvenile Idiopathic Arthritis Therapy. | Q40105064 |
| | Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study | Q40271549 |
| | Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 |
| | Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells. | Q41121054 |
| | Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity | Q41467605 |
| | Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial | Q41565617 |
| | Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation | Q41707767 |
| | Direct conversion of adult skin fibroblasts to endothelial cells by defined factors. | Q41755082 |
| | Transplantation of insulin-producing cells to treat diabetic rats after 90% pancreatectomy | Q41952750 |
| | Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial | Q42672137 |
| | Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial. | Q42708758 |
| | Mesenchymal Stem Cell Treatment for Steroid Refractory Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey | Q43116036 |
| | Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis | Q43588809 |
| | Enabling autologous human liver regeneration with differentiated adipocyte stem cells | Q43818984 |
| | Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy | Q43823986 |
| | Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease. | Q43994723 |
| | Spectral analysis of interviews conducted by Rogers and Ellis | Q44608039 |
| | Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo | Q45238323 |
| | Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study | Q45354237 |
| | A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD. | Q45933896 |
| | Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. | Q45962719 |
| | In vitro differentiation of human adipose tissue-derived stem cells into cells with pancreatic phenotype by regenerating pancreas extract | Q46412665 |
| | Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells | Q46902310 |
| | Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. | Q47074396 |
| | Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population | Q47314750 |
| | Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells | Q47372947 |
| | A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy | Q47968884 |
| | Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study | Q48321211 |
| | Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study. | Q50238199 |
| | Human decidua-derived mesenchymal stromal cells differentiate into hepatic-like cells and form functional three-dimensional structures. | Q50492040 |
| | Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease. | Q50541878 |
| | The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells. | Q50559586 |
| | Induction of pancreatic β cell gene expression in mesenchymal stem cells. | Q50761577 |
| | Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial. | Q50957540 |
| | Nuclear cardiac troponin and tropomyosin are expressed early in cardiac differentiation of rat mesenchymal stem cells. | Q51810929 |
| | Characterisation of insulin-producing cells differentiated from tonsil derived mesenchymal stem cells. | Q53337816 |
| | Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. | Q53609325 |
| | Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues | Q53745526 |
| | Stability of neural differentiation in human adipose derived stem cells by two induction protocols. | Q54333590 |
| | Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis. | Q54586670 |
| | Analysis of results of acute graft-versus-host disease prophylaxis with donor multipotent mesenchymal stromal cells in patients with hemoblastoses after allogeneic bone marrow transplantation | Q61910232 |
| | Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction | Q80246358 |
| | Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children | Q81384595 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 138-151 | |
| P577 | publication date | 2018-07-30 | |
| P1433 | published in | Frontiers of medicine | Q26867043 |
| P1476 | title | Mesenchymal stem cells and immune disorders: from basic science to clinical transition | |
| P478 | volume | 13 | |